Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 1875 · · 10 pages · English
BioDlink International Company Limited on 6ix
Earlier from BioDlink International
- Interim report 2026
- BioDlink Named "Emerging CDMO of the Year" at the 2026 Asia-Pacific Biopharma Excellence Awards
- BioDlink Recognized by Client for Enabling the World's First Dual-Payload ADC to Enter Clinical Trials
- BioDlink Showcases Europe-China CMC Collaboration Amid Developmental Breakthrough
- BioDlink and Lepu Biopharma Celebrate Successful Launch of the World's First EGFR-Targeting ADC Drug, Marking a Major Milestone in Mutual Collaboration in Biologics CMC
Follow BioDlink International into a list and get an email when it puts out news.
Follow BioDlink International